Antibody avidity determination by ELISA using thiocyanate elution.

Area of Science:

• Immunology
• Virology
• Analytical Chemistry

Background:

• Rubella virus infections pose risks, especially during pregnancy.
• Assessing the immune response to rubella vaccination is crucial for public health.
• Antibody avidity, a measure of binding strength, is an important indicator of immune response efficacy.

Purpose of the Study:

• To determine the avidity of human anti-rubella antibodies.
• To establish the pattern of antibody avidity following rubella vaccination.
• To develop and validate a reliable method for measuring antibody avidity.

Main Methods:

• Utilized enzyme-linked immunosorbent assays (ELISA) with a chaotropic thiocyanate ion elution method.
• Developed a modified ELISA assay exposing antibody-antigen complexes to increasing thiocyanate concentrations.
• Quantified antibody avidity using an "affinity index" representing 50% of effective antibody binding.

Main Results:

• Demonstrated the independence of antibody avidity from antibody levels and affinity.
• Established a distinct pattern of antibody avidity in the post-vaccination period.
• Achieved acceptable assay reproducibility with an interplate coefficient of variation of 12.6% and intraplate of 4.1% for the affinity index.

Conclusions:

• The chaotropic thiocyanate elution method in ELISA is effective for measuring anti-rubella antibody avidity.
• Antibody avidity provides valuable insights into the quality and durability of the immune response to rubella vaccination.
• This method can be used to compare immune responses across different patient sera.